EP2099295A4 - Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 - Google Patents

Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3

Info

Publication number
EP2099295A4
EP2099295A4 EP07862162A EP07862162A EP2099295A4 EP 2099295 A4 EP2099295 A4 EP 2099295A4 EP 07862162 A EP07862162 A EP 07862162A EP 07862162 A EP07862162 A EP 07862162A EP 2099295 A4 EP2099295 A4 EP 2099295A4
Authority
EP
European Patent Office
Prior art keywords
prophlyaxis
omega
treatment
fatty acids
atrial fibrillation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07862162A
Other languages
German (de)
English (en)
Other versions
EP2099295A1 (fr
Inventor
Robert A Shalwitz
Roelof M L Rongen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reliant Pharmaceuticals Inc
Original Assignee
Reliant Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reliant Pharmaceuticals Inc filed Critical Reliant Pharmaceuticals Inc
Publication of EP2099295A1 publication Critical patent/EP2099295A1/fr
Publication of EP2099295A4 publication Critical patent/EP2099295A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP07862162A 2006-11-22 2007-11-21 Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3 Withdrawn EP2099295A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86049506P 2006-11-22 2006-11-22
PCT/US2007/024283 WO2008066745A1 (fr) 2006-11-22 2007-11-21 Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3

Publications (2)

Publication Number Publication Date
EP2099295A1 EP2099295A1 (fr) 2009-09-16
EP2099295A4 true EP2099295A4 (fr) 2010-02-24

Family

ID=39468221

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07862162A Withdrawn EP2099295A4 (fr) 2006-11-22 2007-11-21 Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3

Country Status (3)

Country Link
EP (1) EP2099295A4 (fr)
JP (1) JP2010510313A (fr)
WO (1) WO2008066745A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012384A1 (it) 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US8974828B2 (en) 2009-03-18 2015-03-10 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
CN103476405A (zh) * 2011-02-07 2013-12-25 持田制药株式会社 舒张性充血性心力衰竭治疗剂
CN114847965A (zh) 2016-02-01 2022-08-05 英凯达治疗公司 电子监测联合吸入药理学疗法管理心律失常
US10441537B2 (en) 2017-05-10 2019-10-15 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
KR102891439B1 (ko) 2019-08-01 2025-11-25 인카다 테라퓨틱스, 인크. 항부정맥 제제
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
RU2722052C1 (ru) * 2019-12-30 2020-05-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ определения риска развития фибрилляции предсердий у пациентов с ишемической болезнью сердца, принимающих омега-3 полиненасыщенные жирные кислоты, при проведении коронарного шунтирования

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044028A1 (en) * 2001-03-30 2004-03-04 Obukowicz Mark G. Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancer
AU2002352726A1 (en) * 2001-11-15 2003-06-10 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
US8729124B2 (en) * 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
ITMI20022511A1 (it) * 2002-11-26 2004-05-27 Victorix Assets Ltd Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale.
WO2004100964A1 (fr) 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Methode de traitement de la fibrillation auriculaire ou du flutter auriculaire

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BISCIONE FRANCESCO ET AL: "[Effect of omega-3 fatty acids on the prevention of atrial arrhythmias]", ITALIAN HEART JOURNAL. SUPPLEMENT : OFFICIAL JOURNAL OF THE ITALIAN FEDERATION OF CARDIOLOGY JAN 2005, vol. 6, no. 1, January 2005 (2005-01-01), pages 53 - 59, XP009127037, ISSN: 1129-4728 *
KATAN MARTIJN B ET AL: "Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study", JOURNAL OF LIPID RESEARCH, vol. 38, no. 10, 1997, pages 2012 - 2022, XP002560498, ISSN: 0022-2275 *
See also references of WO2008066745A1 *

Also Published As

Publication number Publication date
WO2008066745A9 (fr) 2008-08-28
EP2099295A1 (fr) 2009-09-16
JP2010510313A (ja) 2010-04-02
WO2008066745A1 (fr) 2008-06-05

Similar Documents

Publication Publication Date Title
EP2099295A4 (fr) Prophylaxie et traitement de la fibrillation auriculaire avec des acides gras oméga-3
ZA201003030B (en) Medium-chain length fatty acids and glycerides as nephroprotection agents
EP1904049A4 (fr) Acides gras polyinsatures pour le traitement de la demence et d'etats predementiels
EP2089014A4 (fr) Acides gras oméga-3 et agent dyslipidémique pour la réduction des niveaux d'apo-b
EP2120920A4 (fr) Oxylipines derivées d'acides gras polyinsaturés à chaîne longue et leurs procédé de production et d'utilisation
EP2083815A4 (fr) Statine et acides gras oméga-3 pour la réduction des niveaux d'apo-b
EP2083622A4 (fr) Procédés d'utilisation d'acides gras oméga-3 pour réduire les taux de lp-pla2
EP1919468A4 (fr) Traitement au moyen d'inhibiteurs d'absorption de cholesterol a base d'azetidinone et d'acide gras omega-3 et produit de combinaison de ceux-ci
ZA201303962B (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
ZA201008170B (en) Polypeptides and methods for producing triacyglycerols comprising modified fatty acids
EP2173699A4 (fr) Production et purification d'esters d'acides gras polyinsaturés
PL2214638T3 (pl) Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny
GB0915693D0 (en) Fatty acid formulations and methods of use thereof
IL210318A (en) Acetylation fatty acid salicylates and their uses
IL207309A0 (en) Lipases with high specificity towards short chain fatty acids and uses thereof
PL2034999T3 (pl) Estry DHA i ich zastosowanie w leczeniu i zapobieganiu chorobom sercowo-naczyniowym
EP2114397A4 (fr) Nouveaux conjugués d'acides gras poly-insaturés avec des amines et utilisations thérapeutiques de ceux-ci
ZA200807341B (en) Fatty acid by-products and methods of using same
GB2464886B (en) Preparation of fatty acids in solid form
PL2390338T3 (pl) Delta-8 desaturazy i ich zastosowanie w wytwarzaniu polinienasyconych kwasów tłuszczowych
ZA200807296B (en) Fatty acid by-products and methods of using same
PT2842555T (pt) Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes
EP2068861A4 (fr) Compositions comprenant des acides gras oméga-3 et utilisation de celles-ci dans le traitement d'une maladie des artères périphériques et d'une claudication intermittente
ZA201004144B (en) Fatty acid by-products and methods of using same
IL211844A0 (en) Skin treatments containing carboxylic acid-substitiuted idebenone derivatives and methods of preparation and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090618

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: HR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/06 20060101ALI20100105BHEP

Ipc: A61K 45/06 20060101ALI20100105BHEP

Ipc: A61K 31/202 20060101AFI20100105BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100122

RAX Requested extension states of the european patent have changed

Extension state: HR

Payment date: 20090618

17Q First examination report despatched

Effective date: 20100331

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100811